July 29th, 2024 • Blogs Five Takeaways From Government Investigations on PBMs Probes Show That PBMs are the Culprits Driving Drug Costs and Overall Spend On the heels of this month’s scathing FTC …
April 22nd, 2024 • Blogs An Industry Poised for Progress – Bringing Innovation Back to Copay Our article, “An Industry Poised for Progress – Bringing Innovation Back to Copay” by Matt Turner, President of Pa…
March 8th, 2024 • Blogs Copay Comes Full Circle – An Industry Ready for Disruption Our guest post, “Copay Comes Full Circle – An Industry Ready for Disruption” is featured on Drug Channels, an esta…
April 11th, 2023 • Blogs Identifying Copay Accumulator Impact: Winning the Race for Patient Access Our article, “Identifying Copay Accumulator Impact: Winning the Race for Patient Access” by Matt Turner, President o…
March 24th, 2023 • Blogs Winning the Race for Patient Access: Identifying Copay Accumulator Impact Our guest post, “Winning the Race for Patient Access: Identifying Copay Accumulator Impact” is featured on Drug Chan…
August 30th, 2022 • Blogs Paysign Spotlights the Blood Donation Center, HemaCenter HemaCenter is a blood donation center located in South Miami, FL, that is a wholly owned subsidiary of OrganaBio LLC. He…
August 11th, 2022 • Blogs Understanding the Various Types of Identity Theft and How to Stay Safe Identity theft is a form of fraud in which a criminal steals personal information and uses it without the victim’s per…
July 14th, 2022 • Blogs B Positive Plasma Continues to Open More Center Locations We want to spotlight B Positive Plasma, one of our first plasma clients, as they have opened three centers within four m…
June 28th, 2022 • Blogs Exposing the Facts About Voucher and Bridge Pricing Our guest post, “Exposing the Facts About Voucher and Bridge Pricing”, was featured on Drug Channels, an est…
June 21st, 2022 • Blogs Modern Fintech and How It Has Impacted Traditional Banking Features Fintech is one of the fastest-growing areas for financial institutions. Financial technology, or fintech as we refer to …
